Medical technology manufacturer Masimo earned FDA clearance this week for its O3 regional oximetry technology.
Supply Chain
The latest showdown over high drug costs features pharmaceutical giant Novartis facing off against a large Latin American country.
KemPharm announced Monday that the Food and Drug Administration did not approve the drug maker's abuse-deterrent version of a painkiller.
A safety warning issued in 2011 by the Food and Drug Administration over the dosage of an antibiotic backfired, leading to intensified depressive symptoms and more hospitalizations among patients whose conditions were previously stabilized on higher doses of the drugs,…
On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments.
On Monday, researchers announced that Victoza, a diabetes drug produced by Novo Nordisk, prevents heart attacks, strokes and cardiovascular deaths.
In 2012, the Food and Drug Administration Safety and Innovation Act gave the FDA expanded powers to monitor and resolve drug shortages. A recent paper in Health Affairs evaluated trends in drug shortages before and after the passage of act…
An implantable, nerve-stimulating device shows promise to reduce the symptoms of obstructed sleep apnea in patients unable to tolerate standard therapy.
Researchers at Boston-based Wyss Institute developed a rapid diagnostic assay that can inform physicians within an hour if a patient has a systemic infection and requires hospitalization for aggressive intervention therapy.
Engaging frontline staff in quality improvement initiatives to organize operating room supplies helps set a precedent for sustained supply chain coordination, according to Stephanie Davis, MSHA, RN, CNOR, CSSM, vice president of Surgical Services for Nashville, Tenn.-based Hospital Corporation of…